Should definitive concurrent chemoRT be offered to patients with anal canal SCCa with common iliac nodal involvement (by definition M1 disease) without evidence for other distant disease?  


Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Emeritus Professor
I agree with Joel and Chris, if a PET scan has bee...
Radiation Oncologist at Washington University School of Medicine
Agree with treating oligometastatic M1 anal cancer...
Sign in or Register to read more